SO
SGMO

STRS Ohio’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

STRS Ohio’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-61,300
Closed -$41K – 2081
2024
Q1 		$41K Hold
61,300
– – ﹤0.01% 1783
2023
Q4 		$33K Hold
61,300
– – ﹤0.01% 1817
2023
Q3 		$36K Hold
61,300
– – ﹤0.01% 1832
2023
Q2 		$79K Hold
61,300
– – ﹤0.01% 1756
2023
Q1 		$107K Hold
61,300
– – ﹤0.01% 1706
2022
Q4 		$192K Hold
61,300
– – ﹤0.01% 1599
2022
Q3 		$300K Hold
61,300
– – ﹤0.01% 1488
2022
Q2 		$253K Buy
61,300
+3,500
+6% +$15.1K ﹤0.01% 1535
2022
Q1 		$335K Hold
57,800
– – ﹤0.01% 1566
2021
Q4 		$433K Hold
57,800
– – ﹤0.01% 1525
2021
Q3 		$520K Buy
57,800
+17,000
+42% +$168K ﹤0.01% 1494
2021
Q2 		$488K Buy
40,800
+4,700
+13% +$53.2K ﹤0.01% 1568
2021
Q1 		$452K Buy
36,100
+3,400
+10% +$45.8K ﹤0.01% 1610
2020
Q4 		$510K Buy
+32,700
New +$383K ﹤0.01% 1469
2018
Q4 		– Sell
-23,500
Closed -$398K – 2133
2018
Q3 		$398K Sell
23,500
-13,000
-36% -$198K ﹤0.01% 1487
2018
Q2 		$518K Buy
36,500
+3,300
+10% +$54.8K ﹤0.01% 1355
2018
Q1 		$630K Buy
33,200
+3,100
+10% +$66.3K ﹤0.01% 1216
2017
Q4 		$493K Hold
30,100
– – ﹤0.01% 1328
2017
Q3 		$451K Buy
+30,100
New +$333K ﹤0.01% 1380
2014
Q4 		– Sell
-6,100
Closed -$66K – 1794
2014
Q3 		$66K Buy
6,100
+2,200
+56% +$28.7K ﹤0.01% 1615
2014
Q2 		$60K Hold
3,900
– – ﹤0.01% 1603
2014
Q1 		$71K Buy
+3,900
New +$75.2K ﹤0.01% 1589
2013
Q4 		– Sell
-36,100
Closed -$378K – 1806
2013
Q3 		$378K Hold
36,100
– – ﹤0.01% 1301
2013
Q2 		$282K Buy
+36,100
New +$315K ﹤0.01% 1422

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

STRS Ohio's SGMO Position: Q2 2024 in Review

STRS Ohio sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 61,300 shares — an estimated $41K sold.

STRS Ohio first reported a position in SGMO in Q2 2013 and held it in 24 quarters. The position peaked at $630K in Q1 2018. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

  • STRS Ohio reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • STRS Ohio sold 61,300 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $41K.
  • STRS Ohio first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 24 quarters.
  • STRS Ohio's SANGAMO THERAPEUTICS INC position peaked at $630K in Q1 2018.
  • 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on STRS Ohio's 13F filing for Q2 2024, filed 5 Aug 2024.